| Diuretic dose and NYHA functional class are independent predictors of mortality in patients with transthyretin cardiac amyloidosis RK Cheng, WC Levy, A Vasbinder, S Teruya, J De Los Santos, D Leedy, ... Cardio Oncology 2 (3), 414-424, 2020 | 63 | 2020 |
| Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19 A Vasbinder, E Anderson, H Shadid, H Berlin, M Pan, TU Azam, I Khaleel, ... Diabetes Care 45 (3), 692-700, 2022 | 56 | 2022 |
| Lack of association between neurohormonal blockade and survival in transthyretin cardiac amyloidosis RK Cheng, A Vasbinder, WC Levy, P Goyal, JM Griffin, DJ Leedy, ... Journal of the American Heart Association 10 (24), e022859, 2021 | 38 | 2021 |
| Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis G Hindy, DJ Tyrrell, A Vasbinder, C Wei, F Presswalla, H Wang, P Blakely, ... The Journal of clinical investigation 132 (24), 2022 | 35 | 2022 |
| Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced myocarditis A Vasbinder, YA Chen, A Procureur, A Gradone, TU Azam, D Perry, ... Cardio Oncology 4 (5), 689-700, 2022 | 28 | 2022 |
| The association between heart failure and incident cancer in women: an analysis of the Women's Health Initiative DJ Leedy, KW Reding, AL Vasbinder, GL Anderson, A Barac, ... European journal of heart failure 23 (10), 1712-1721, 2021 | 27 | 2021 |
| Lifestyle and cardiovascular risk factors associated with heart failure subtypes in postmenopausal breast cancer survivors KW Reding, RK Cheng, A Vasbinder, RM Ray, A Barac, CB Eaton, ... Cardio Oncology 4 (1), 53-65, 2022 | 24 | 2022 |
| Angiotensin‐converting enzyme inhibitors, angiotensin II receptor blockers, and outcomes in patients hospitalized for COVID‐19 M Pan, A Vasbinder, E Anderson, T Catalan, HR Shadid, H Berlin, ... Journal of the American Heart Association 10 (24), e023535, 2021 | 22 | 2021 |
| Relationship between preexisting cardiovascular disease and death and cardiovascular outcomes in critically ill patients with COVID-19 A Vasbinder, C Meloche, TU Azam, E Anderson, T Catalan, H Shadid, ... Circulation: Cardiovascular quality and outcomes 15 (10), e008942, 2022 | 21 | 2022 |
| Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes AM Balinski, AL Vasbinder, CC Kerndt, TC Catalan, NP Parry, ... Cancer Medicine 12 (3), 2356-2367, 2023 | 17 | 2023 |
| Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19 S Luo, A Vasbinder, JM Du‐Fay‐de‐Lavallaz, JMD Gomez, T Suboc, ... Journal of the American Heart Association 11 (18), e025198, 2022 | 12 | 2022 |
| Cardiovascular events after hematopoietic stem cell transplant: incidence and risk factors A Vasbinder, CW Hoeger, T Catalan, E Anderson, C Chu, M Kotzin, J Xie, ... Cardio Oncology 5 (6), 821-832, 2023 | 11 | 2023 |
| Inflammatory, oxidative stress, and cardiac damage biomarkers and radiation-induced fatigue in breast cancer survivors A Vasbinder, H Thompson, O Zaslavksy, SR Heckbert, N Saquib, ... Biological Research For Nursing 24 (4), 472-483, 2022 | 9 | 2022 |
| Risk of metabolic syndrome and metabolic phenotypes in relation to biomarker-calibrated estimates of energy and protein intakes: an investigation from the Women’s Health Initiative A Vasbinder, LF Tinker, ML Neuhouser, M Pettinger, L Hale, C Di, ... The American Journal of Clinical Nutrition 113 (3), 706-715, 2021 | 8 | 2021 |
| Assay-related differences in SuPAR levels: implications for measurement and data interpretation A Vasbinder, LM Raffield, Y Gao, G Engstrom, AA Quyyumi, AP Reiner, ... Journal of Nephrology 36 (1), 157-159, 2023 | 7 | 2023 |
| Postdiagnosis physical activity: association with long-term fatigue and sleep disturbance in older adult breast cancer survivors A Vasbinder, KW Reding, D Wang, CJ Han, O Zaslavsky, DJ Langford, ... Clinical journal of oncology nursing 24 (4), 381, 2020 | 6 | 2020 |
| A review of research on the intersection between breast cancer and cardiovascular research in the Women’s Health Initiative (WHI) S Raychaudhuri, CM Dieli-Conwright, RK Cheng, A Barac, KW Reding, ... Frontiers in Oncology 12, 1039246, 2023 | 5 | 2023 |
| Toward a better understanding of the differential impact of heart failure phenotypes after breast cancer KW Reding, RK Cheng, A Barac, A Vasbinder, G Hovsepyan, M Stefanick, ... Journal of Clinical Oncology 40 (32), 3688-3691, 2022 | 5 | 2022 |
| Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis. JACC CardioOncol. 2020 Sep; 2 (3): 414–24 RK Cheng, WC Levy, A Vasbinder, S Teruya, J De Los Santos, D Leedy | 5 | |
| Procureur A, Gradone A, Azam TU, Perry D, Shadid H, Anderson E, Catalan T, Blakely P, et al. Biomarker trends, incidence, and outcomes of immune checkpoint inhibitor–induced … A Vasbinder, Y Chen JACC CardioOncol 4, 689-700, 2022 | 4 | 2022 |
